PROFIL PASIEN HEPATITIS B KRONIK DI POLI RAWAT JALAN YANG MENDAPATKAN TERAPI ANTIVIRUS DI DEPARTEMEN PENYAKIT DALAM RSUD DR. SOETOMO PERIODE 2010-2015
Background: Hepatitis B is a liver disease caused by hepatitis B virus included in class hepadnavirus and can lead to acute or chronic inflammation of the liver. Hepatitis B becomes number 10 in the world as one of the highest death diseases. In Indonesia, about 13 millions people are infected wi...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses and Dissertations NonPeerReviewed |
| Language: | Indonesian Indonesian |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/66543/1/FK.PD.216.17%20.%20Del.p%20-%20ABSTRAK.pdf http://repository.unair.ac.id/66543/2/FK.PD.216.17%20.%20Del.p%20-%20SEC.pdf http://repository.unair.ac.id/66543/ http://lib.unair.ac.id |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | Indonesian Indonesian |
| Summary: | Background: Hepatitis B is a liver disease caused by hepatitis B virus included in
class hepadnavirus and can lead to acute or chronic inflammation of the liver.
Hepatitis B becomes number 10 in the world as one of the highest death diseases. In
Indonesia, about 13 millions people are infected with CHB (Chronic Hepatitis B).
Chronic Hepatitis B (CHB) virus has the capability of 50 to 100 times more infectious
than HIV (Human Immunodeficiency Virus), and CHB can survive outside the human
body for 7 days, while HIV can not
Objective: To know the clinical profiles and therapy of CHB patients.
Methode: This research uses descriptive method with cross sectional design. This
research was conducted at the Department of Interna dr. Soetomo Hospital. This
research was conducted from March 2015-2017. The samples were all patients with
CHB poly outpatient treatment at the Department of Interna period 2010-2015. The
research variables are CHB, laboratory tests, Hepatitis B therapy, results of antiviral
therapy. The data obtained through medical records in this study were analyzed using
the computer thoroughly and then described
Results: This research has 62 patients as sample, most patients come from a lifespan
of 41-60 years (56.5%), the average age of the sample is 45.5 + 11.9 years. Most
patients with male sex (77.4%). HBeAg positive patients has higher levels of as much
as 45.2%. HBV DNA levels on average are 2,02x108 + 9,45x108. The use Telbivudin
as a treatment option as much as 79.1%.
Conclusion: Hepatitis B patients mostly came from a lifespan of 41-60 years, with
the oldest aged 76 years and most patients gender to male. Increasing value in SGOT
and SGPT. The use of most drugs is Telbivudin |
|---|